UnknownNCT05630313

Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil

Studying Acute disseminated encephalomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Principal Investigator
Patrícia de Oliveira, MD
Instituto Fernandes Figueira
Enrollment
100 enrolled
Eligibility
5 years · All sexes
Timeline
2022 – 2023

Study locations (1)

Collaborators

Oswaldo Cruz Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05630313 on ClinicalTrials.gov

Other trials for Acute disseminated encephalomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Acute disseminated encephalomyelitis →

← Back to all trials